Literature DB >> 27197440

[A Case of Bacteremia Caused by Ochrobacterium intermedium].

Jun Hirai, Yuka Yamagishi, Daisuke Sakanashi, Yusuke Koizumi, Hiroyuki Suematsu, Hiroshige Mikamo.   

Abstract

We report herein on a case of bacteremia caused by Ochrobactrum intermedium (O. intermedium) identified with biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). An 86-year-old man was admitted to our hospital with paralysis of the right side of the body and dysphagia. He was diagnosed as having a pontine infarction based on the brain MRI findings and was admitted to hospital to have anti-platelet therapy. Three days after admission, he had a fever. Although he had redness and swelling at the peripheral venous catheter insertion site, he was diagnosed as having aspiration pneumonia, since he had fine crackles on auscultation. Soon after taking two sets of blood cultures and removal of the peripheral venous catheter, sulbactam/ampicillin (SBT/ABPC) was administrated. Fifty three hours after incubation, gram-negative bacilli was detected from an aerobic bottle and identified as O. intermedium with MALDI-TOF MS (Bruker MS). Antimicrobial chemotherapy was changed to meropenem (MEPM). He was treated for a total of seven days, and recovered without relapse. Infection caused by O. intermedium has been very uncommon, however, O. intermedium has been recognized as an emerging pathogen in immunodeficient and immunocompetent patients. Since identification of Ochrobactrum species by biochemical methods could be difficult, MALDI-TOF MS might be helpful to clarify Ochrobactrum species just as in the present case.

Entities:  

Mesh:

Year:  2016        PMID: 27197440     DOI: 10.11150/kansenshogakuzasshi.90.129

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  1 in total

1.  The first case of Ochrobactrum intermedium bacteremia in a pediatric patient with malignant tumor.

Authors:  Wenjing Wu; Yongmei Jiang; Wei Zhou; Xingxin Liu; Linghan Kuang
Journal:  BMC Infect Dis       Date:  2021-12-14       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.